Quercetin and Its In Vivo Metabolites Inhibit Neutrophil-Mediated Low-Density Lipoprotein Oxidation
- 1 May 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 56 (10) , 3609-3615
Abstract
This study examined the effects of metabolic transformation of the common dietary flavonoid, quercetin, on its ability to protect low-density lipoprotein (LDL) from neutrophil-mediated modification. Quercetin was shown to be effective in protecting LDL against neutrophil-mediated modification at physiological concentrations (1 µM) and appears to act by inhibiting myeloperoxidase (MPO)-catalyzed oxidation (IC50 = 1.0 µM). Quercetin was also shown to protect against radical-induced [2,2′-azobis(2-methylpropionamidine)dihydrochloride] oxidation (IC50 = 1.5 µM). Studies of structure−activity relationships showed that methylation at the 3′-position or glucuronidation at the 3-position did not significantly affect inhibition by quercetin of the MPO activity, but conjugations at both positions significantly reduce its activity. Our results suggest that the common dietary flavonoid, quercetin, and some of its major in vivo metabolites are potential inhibitors of MPO at physiological concentrations. Dietary flavonoids that could modify MPO activity could protect lipoproteins from damage in chronic inflammatory states such as cardiovascular disease.Keywords
This publication has 37 references indexed in Scilit:
- Protein carbamylation links inflammation, smoking, uremia and atherogenesisNature Medicine, 2007
- Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial InfarctionJACC, 2007
- Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular diseaseCurrent Opinion in Lipidology, 2006
- Polyphenols and cardiovascular disease: effects on endothelial and platelet functionThe American Journal of Clinical Nutrition, 2005
- Polyphenols and disease risk in epidemiologic studiesThe American Journal of Clinical Nutrition, 2005
- Role of Oxidative Modifications in AtherosclerosisPhysiological Reviews, 2004
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasmaBlood, 2002
- Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic IntimaJournal of Biological Chemistry, 1997